TriSalus Life Sciences Inc. announced that the Centers for Medicare & Medicaid Services (CMS) has created a New Technology Healthcare Common Procedure Coding System (HCPCS) code for procedures involving the TriNav® Infusion System. This new code, HCPCS C9797, has been assigned to the Ambulatory Payment Classification (APC) 5194 - Level 4 Endovascular Procedures. The new code will become effective on January 1, 2024, and may be reported by hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs).
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.39 USD | -7.49% | -4.48% | +11.12% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.12% | 264M | |
+9.42% | 115B | |
+11.84% | 106B | |
-2.71% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- TLSI Stock
- News TriSalus Life Sciences, Inc.
- TriSalus Life Sciences Announces CMS Reimbursement for the TriNav Infusion System via Assignment of New Technology Healthcare Common Procedure Coding System Code